权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Rho GTPases and Actin Cytoskeletal Function in Renal Ischemia

肾缺血中的 Rho GTP 酶和肌动蛋白细胞骨架功能

基本信息

批准号：
7856981
负责人：
Simon J. Atkinson
金额：
$ 32.18万
依托单位：
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
起止时间：
2008-05-01 至 2013-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7856981
关键词：
Actins Acute Kidney Failure Address Adenovirus Vector Affect Animal Model Animals Award Biochemical Biological Assay Blood flow Cell Culture Techniques Cell Polarity Cell Survival Cell physiology Cells Cellular Morphology Cellular Stress Clinical Complex Cytoskeletal Modeling Cytoskeleton Data Endothelial Cells Epithelial Cells Figs - dietary Fluorescence Microscopy Functional disorder Goals Guanosine Triphosphate Phosphohydrolases In Vitro Injury Ischemia Kidney Life Link Maintenance Measurement Measures Mediating Metabolic Morbidity - disease rate Outcome Pathway interactions Patient Care Patients Pharmaceutical Preparations Pharmacotherapy Phosphorylation Site Phosphotransferases Photons Play Proteins RNA Interference Recovery Regulation Relative (related person)Renal function Role Signal Pathway Signal Transduction Sirolimus Structure TSC1 gene TSC1/2 gene TSC2 gene Testing Translating Tubular formation adenylate kinase cell injury depressed human FRAP1 protein in vivo in vivo Model injury and repair insight kidney cell monomer mortality mutant novel polymerization renal ischemia rho rho GTP-Binding Proteins sensor success therapy design

项目摘要

DESCRIPTION (provided by applicant): The persistence of ischemic acute renal failure as a major cause of morbidity and mortality in hospitalized patients and the relative lack of improvement in outcomes for these patients challenges us the better understand the cellular mechanisms underlying this injury. Disruption of the actin cytoskeletal organization that normally underpins the structure and function of proximal tubule epithelial cells is well-established as an early and critical aspect of injury, with direct consequences for renal function and cell survival. In the previous years of this award we have shown that Rho GTPases play critical roles that may mediate the cytoskeletal alterations observed with ischemia. Moreover, we showed that activities of RhoA, Rac1 and Cdc42 are sensitive to ATP depletion, but that the activity of each protein is differentially affected by depletion. We proposed that alterations in Rho GTPase activity and consequent cytoskeletal disruption are the result of signaling through the AMPK-TSC1/2 pathway resulting in inactivation of the type II (rapamycin insensitive) mTor complex 2, which has recently been shown to regulate the cytoskeleton through Rho GTPases or via novel mTOR independent pathways downstream of TSC1/2. We propose studies to test and elucidate our proposed mechanism using complementary studies in cell culture and in animal models of renal ischemia. We propose four specific aims to address our central hypothesis: 1) Investigate the activation of AMPK by ATP depletion in vitro and ischemia in vivo; 2) Investigate the role of TSC1/2 and Rheb GTPase signaling on Rho GTPase activity and cytoskeletal organization in vitro and in vivo; 3) Determine the effect of AMPK activation on the type II mTOR complex; 4) Determine the effect of altered AMPK, TSC1/2, Rheb and mTOR signaling on actin cytoskeletal organization and proximal tubule cell function in animal models of ischemic renal injury. These studies will determine the key mechanism linking energy depletion to cytoskeletal alterations, and afford an opportunity to identify targets for novel therapies. Narrative Ischemia (loss of blood flow) is a major cause of acute kidney failure. Currently there is a poor understanding of the way that kidney cells respond to ischemia, which makes it difficult to design therapies or drugs. The studies proposed will test a possible mechanism leading to cell injury that could be a target for drug therapy.

描述（由申请人提供）：